LivingGLP1
Study S002065

An Open-label,Sequential,Single-site Study to Evaluate the Pharmacokinetics of Simvastatin When Coadministered With Polyethylene Glycol Loxenatide (PEX168) in Healthy Adult Subjects

Registration

Registration
NCT02447601
Study type
INTERVENTIONAL
Phase
PHASE1
Masking
NONE
Status
COMPLETED
Enrollment
16
Start
2015-03-30
Primary completion
2015-05-14
Lead sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:PEX168; DRUG:Simvastatin
Results posted
FALSE
Individual participant data sharing
NO
Secondary identifiers
OTHER:PEX168-Ik

Registered primary outcomes

  • Plasma concentrations of simvastatin and simvastatin acid. [Baseline to Day34]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.